These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32531846)

  • 21. Pathogenicity Reclasssification of
    Motta FL; Martin RP; Porto FBO; Wohler ES; Resende RG; Gomes CP; Pesquero JB; Sallum JMF
    Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31878136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic factors associated with age-related macular degeneration: identification of a novel PRPH2 single nucleotide polymorphism associated with increased risk of the disease.
    Ulańczyk Z; Grabowicz A; Mozolewska-Piotrowska K; Safranow K; Kawa MP; Pałucha A; Krawczyk M; Sikora P; Matczyńska E; Machaliński B; Machalińska A
    Acta Ophthalmol; 2021 Nov; 99(7):739-749. PubMed ID: 33354892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PRPH2-Associated Macular Dystrophy in 4 Family Members with a Novel Mutation.
    Choi H; Cloutier A; Lally D
    Ophthalmic Genet; 2022 Apr; 43(2):235-239. PubMed ID: 34906036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features and molecular genetics of patients with ABCA4-retinal dystrophies.
    Holtan JP; Aukrust I; Jansson RW; Berland S; Bruland O; Gjerde BL; Stokowy T; Bojovic O; Forsaa V; Austeng D; Rødahl E; Bredrup C; Knappskog PM; Bragadóttir R
    Acta Ophthalmol; 2021 Aug; 99(5):e733-e746. PubMed ID: 33258285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macular dystrophy associated with the Arg172Trp substitution in peripherin/RDS: genotype-phenotype correlation.
    Anand S; Sheridan E; Cassidy F; Inglehearn C; Williams G; Springell K; Allgar V; Kelly TL; McKibbin M
    Retina; 2009 May; 29(5):682-8. PubMed ID: 19262438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral pigmented lesions in
    Al-Ani HH; Sheck L; Vincent AL
    Ophthalmic Genet; 2021 Aug; 42(4):383-391. PubMed ID: 33706644
    [No Abstract]   [Full Text] [Related]  

  • 27. Molecular diagnostic testing by eyeGENE: analysis of patients with hereditary retinal dystrophy phenotypes involving central vision loss.
    Alapati A; Goetz K; Suk J; Navani M; Al-Tarouti A; Jayasundera T; Tumminia SJ; Lee P; Ayyagari R
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(9):5510-21. PubMed ID: 25082885
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Zhu T; Chen DF; Wang L; Wu S; Wei X; Li H; Jin ZB; Sui R
    Br J Ophthalmol; 2021 May; 105(5):694-703. PubMed ID: 32675063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel molecular mechanisms for Prph2-associated pattern dystrophy.
    Chakraborty D; Strayve DG; Makia MS; Conley SM; Kakahel M; Al-Ubaidi MR; Naash MI
    FASEB J; 2020 Jan; 34(1):1211-1230. PubMed ID: 31914632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cone-rod dystrophy, intrafamilial variability, and incomplete penetrance associated with the R172W mutation in the peripherin/RDS gene.
    Michaelides M; Holder GE; Bradshaw K; Hunt DM; Moore AT
    Ophthalmology; 2005 Sep; 112(9):1592-8. PubMed ID: 16019073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinal dystrophies and variants in PRPH2.
    Palma MMD; Martin D; Salles MV; Motta FLT; Abujamra S; Sallum JMF
    Arq Bras Oftalmol; 2019; 82(2):158-160. PubMed ID: 30726412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ABCA4 and ROM1: implications for modification of the PRPH2-associated macular dystrophy phenotype.
    Poloschek CM; Bach M; Lagrèze WA; Glaus E; Lemke JR; Berger W; Neidhardt J
    Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4253-65. PubMed ID: 20335603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RPE65-related retinal dystrophy: Mutational and phenotypic spectrum in 45 affected patients.
    Lopez-Rodriguez R; Lantero E; Blanco-Kelly F; Avila-Fernandez A; Martin Merida I; Del Pozo-Valero M; Perea-Romero I; Zurita O; Jiménez-Rolando B; Swafiri ST; Riveiro-Alvarez R; Trujillo-Tiebas MJ; Carreño Salas E; García-Sandoval B; Corton M; Ayuso C
    Exp Eye Res; 2021 Nov; 212():108761. PubMed ID: 34492281
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Daftarian N; Mirrahimi M; Sabbaghi H; Moghadasi A; Zal N; Dehghan Banadaki H; Ahmadieh H; Suri F
    Ophthalmic Genet; 2019 Oct; 40(5):436-442. PubMed ID: 31618092
    [No Abstract]   [Full Text] [Related]  

  • 35. The Interplay between Peripherin 2 Complex Formation and Degenerative Retinal Diseases.
    Tebbe L; Kakakhel M; Makia MS; Al-Ubaidi MR; Naash MI
    Cells; 2020 Mar; 9(3):. PubMed ID: 32213850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene therapy for PRPH2-associated ocular disease: challenges and prospects.
    Conley SM; Naash MI
    Cold Spring Harb Perspect Med; 2014 Aug; 4(11):a017376. PubMed ID: 25167981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel variants identified with next-generation sequencing in Polish patients with cone-rod dystrophy.
    Wawrocka A; Skorczyk-Werner A; Wicher K; Niedziela Z; Ploski R; Rydzanicz M; Sykulski M; Kociecki J; Weisschuh N; Kohl S; Biskup S; Wissinger B; Krawczynski MR
    Mol Vis; 2018; 24():326-339. PubMed ID: 29769798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ROM1 contributes to phenotypic heterogeneity in PRPH2-associated retinal disease.
    Strayve D; Makia MS; Kakakhel M; Sakthivel H; Conley SM; Al-Ubaidi MR; Naash MI
    Hum Mol Genet; 2020 Sep; 29(16):2708-2722. PubMed ID: 32716032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prph2 mutations as a cause of electronegative ERG.
    Ba-Abbad R; Robson AG; Yap YC; Moore AT; Webster AR; Holder GE
    Retina; 2014 Jun; 34(6):1235-43. PubMed ID: 24608669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PRPH2/RDS and ROM-1: Historical context, current views and future considerations.
    Stuck MW; Conley SM; Naash MI
    Prog Retin Eye Res; 2016 May; 52():47-63. PubMed ID: 26773759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.